| RULE NAME |
VA-WH HIRISK MEDS (MODERATE/HIGH RISK) PREG RULE |
| DISPLAY NAME |
Known or Potential Teratogen (FDA Cat. D or Cat. C w/other data) |
| RULE DESCRIPTION |
Teratogenic Medications Order Check - Category D and selected C Meds
Due for: women of childbearing age (10-52)
Exclusions: documented hysterectomy, documented tubal ligation more recent
than documented tubal reanastomosis
|
| CLASS |
NATIONAL |
| EDIT HISTORY |
-
- EDIT DATE: 2015-05-21 13:14:03
- EDIT BY: USER,SEVENTEEN
- EDIT COMMENTS:
Exchange Install
|
| STATUS |
TESTING |
| REMINDER DEFINITION |
VA-WH HIRISK ORDER CHECK - PREGNANT |
| DEFINITION EVALUATION STATUS |
APPLICABLE |
| OUTPUT TEXT |
BOTH ORDER CHECK AND DEFINITION TEXT |
| SEVERITY |
MEDIUM |
| ORDER CHECK TEXT |
Use during pregnancy increases or may increase the risk for birth
\\prescriber.
\\defects or other adverse pregnancy outcomes (see REPROTOX).
\\ \\1) Pregnancy status should be determined.
\\2) Discuss the risks and benefits of medication treatment for a mother
\\and fetus and the risks of untreated disease. Potential treatment
\\benefits may warrant use during pregnancy despite risks.
\\3) Provide contraceptive counseling and encourage effective
\\contraception for patients who are not trying to conceive.
\\4) Such counseling must be documented in the medical record by the
|
| NO. OF ORDER CHECK TEXT LINES |
10 |
| NO. OF FORMATTED LINES |
11 |
| FORMATTED ORDER CHECK TEXT |
Use during pregnancy increases or may increase the risk for birth
4) Such counseling must be documented in the medical record by the
prescriber.
defects or other adverse pregnancy outcomes (see REPROTOX).
1) Pregnancy status should be determined.
2) Discuss the risks and benefits of medication treatment for a mother
and fetus and the risks of untreated disease. Potential treatment
benefits may warrant use during pregnancy despite risks.
3) Provide contraceptive counseling and encourage effective
contraception for patients who are not trying to conceive.
|
